首页 | 本学科首页   官方微博 | 高级检索  
     


Hepatocellular carcinoma treated with sorafenib: early detection of treatment response and major adverse events by contrast‐enhanced US
Authors:Katsutoshi Sugimoto  Fuminori Moriyasu  Kazuhiro Saito  Nicolas Rognin  Naohisa Kamiyama  Yoshihiro Furuichi  Yasuharu Imai
Affiliation:1. Department of Gastroenterology and Hepatology, Tokyo Medical University, , Tokyo, Japan;2. Department of Radiology, Tokyo Medical University, , Tokyo, Japan;3. Toshiba Medical Research Institute USA Inc., , Redmond, WA, USA;4. Ultrasound Division, Toshiba Medical Systems Corporation, , Otawara, Japan
Abstract:
Keywords:adverse event  contrast media  dose escalation  hepatocellular carcinoma  sorafenib  ultrasound
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号